Statement of Principles concerning fibromyalgia No. 13 of 2014

Administered by Department of Veterans' Affairs

Legislation au F2014L00016 Not in force Legislative Instrument

Legislation content

REPATRIATION MEDICAL AUTHORITY

 

INSTRUMENT NO. 13 of 2014

 

VETERANS’ ENTITLEMENTS ACT 1986

MILITARY REHABILITATION AND COMPENSATION ACT 2004

 

EXPLANATORY NOTES FOR TABLING

 

 

  1. The Repatriation Medical Authority (the Authority) has determined, under subsection 196B(2) of the Veterans’ Entitlements Act 1986 (the VEA), Statement of Principles Instrument No. 13 of 2014 concerning fibromyalgia and death from fibromyalgia.

 

2.             The Authority is of the view that there is sound medical-scientific evidence that indicates that fibromyalgia and death from fibromyalgia can be related to particular kinds of service.  The Authority has therefore determined this Statement of Principles concerning fibromyalgia pursuant to subsection 196B(2) of the VEA.

 

3.             Pursuant to the provisions of the VEA and the Military Rehabilitation and Compensation Act 2004 (the MRCA), claims for pension under the VEA or compensation under the MRCA are determined by the Repatriation Commission or the Military Rehabilitation and Compensation Commission by reference to Statements of Principles issued by the Authority pursuant to the VEA.

 

4.             The Statement of Principles sets out the factors that must as a minimum exist, and which of those factors must be related to the following kinds of service rendered by a person:

 

 operational service under the VEA;

 peacekeeping service under the VEA;

 hazardous service under the VEA;

 British nuclear test defence service under the VEA;

 warlike service under the MRCA;

 non-warlike service under the MRCA,

 

before it can be said that a reasonable hypothesis has been raised connecting fibromyalgia or death from fibromyalgia, with the circumstances of that service.

 

5.             The Repatriation Commission, Military Rehabilitation and Compensation Commission, Veterans’ Review Board or Administrative Appeals Tribunal cannot accept any claim for pension; or a claim for liability or compensation relating to fibromyalgia or death from fibromyalgia that was lodged on or after 1 June 1994 in the case of the VEA, or 1 July 2004 in the case of the MRCA respectively, unless this Statement of Principles upholds that claim (subsection 120A(3) of the VEA or subsection 338(3) of the MRCA).

 

6.             This new Instrument results from an investigation notified by the Authority in the Government Notices Gazette of 14 December 2011 concerning fibromyalgia in accordance with section 196G of the VEA.  The investigation involved an examination of the sound medical-scientific evidence available to the Authority.

 

7.             This new instrument incorporates a reference at paragraph 3(b) to The American College of Rheumatology Preliminary Diagnostic Criteria for Fibromyalgia and Measurement of Symptom Severity 2010 which was published in Arthritis Care and Research Vol 62, No 5, May 2010, pp 600 – 610.  A copy of that publication is available from the offices of the Repatriation Medical Authority, Level 8, Bank of Queensland Building, 259 Queen St, Brisbane, Queensland 4000, by contacting the Registrar on telephone (07) 3815 9404.

 

8.             Prior to determining this Instrument, the Authority advertised its intention to undertake an investigation in relation to fibromyalgia in the Government Notices Gazette of 14 December 2011, and circulated a copy of the notice of intention to investigate to a wide range of organisations representing veterans, service personnel and their dependants.  The Authority invited submissions from the Repatriation Commission, organisations and persons referred to in section 196E of the VEA, and any person having expertise in the field.  One submission was received for consideration by the Authority during the investigation.

 

9.             This instrument is compatible with the Human Rights and Freedoms recognised or declared in the International Instruments listed in Section 3 of the Human Rights (Parliamentary Scrutiny) Act 2011. A Statement of Compatibility with Human Rights follows.

 

10.         The determining of this new Instrument finalises the investigation in relation to fibromyalgia as advertised in the Government Notices Gazette of 14 December 2011.

 

11.         A list of references relating to the above condition is available to any person or organisation referred to in subsection 196E(1)(a) to (c) of the VEA.  Any such request must be made in writing to the Repatriation Medical Authority at the following address:

 

The Registrar

Repatriation Medical Authority

GPO Box 1014

BRISBANE    QLD    4001

 


Statement of Compatibility with Human Rights

(Prepared in accordance with Part 3 of the Human Rights (Parliamentary Scrutiny) Act 2011)

 

Instrument No.:   Statement of Principles No. 13 of 2014

Kind of Injury, Disease or Death: Fibromyalgia

 

This Legislative Instrument is compatible with the human rights and freedoms recognised or declared in the international instruments listed in section 3 of the Human Rights (Parliamentary Scrutiny) Act 2011.

Overview of the Legislative Instrument

1. This Legislative Instrument is determined pursuant to subsection 196B(8) of the Veterans' Entitlements Act 1986 (the VEA) for the purposes of the VEA and the Military Rehabilitation and Compensation Act 2004 (the MRCA).

2. This Legislative Instrument:-

  • facilitates claimants in making, and the Repatriation Commission in assessing, claims under the VEA and the MRCA respectively, by specifying the circumstances in which medical treatment and compensation can be extended to eligible persons who have fibromyalgia;
  • facilitates the review of such decisions by the Veterans' Review Board and the Administrative Appeals Tribunal; and
  • outlines the factors which the current sound medical-scientific evidence indicates must as a minimum exist, before it can be said that a reasonable hypothesis has been raised, connecting fibromyalgia with the circumstances of eligible service rendered by a person, as set out in clause 4 of the Explanatory Notes.

3. The Instrument is assessed as being a technical instrument which improves the medico-scientific quality of outcomes under the VEA and the MRCA. 

Human Rights Implications

4. This Legislative Instrument does not derogate from any human rights. It promotes the human rights of veterans, current and former Defence Force members as well as other persons such as their dependents, including:

  • the right to social security (Art 9, International Covenant on Economic, Social and Cultural Rights; Art 26, Convention on the Rights of the Child and Art 28, Convention on the Rights of Persons with Disabilities) by helping to ensure that the qualifying conditions for the benefit are 'reasonable, proportionate and transparent'[1];
  • the right to an adequate standard of living (Art 11, ICSECR; Art 27, CRC and Art 28, CRPD) by facilitating the assessment and determination of social security benefits;
  • the right to the enjoyment of the highest attainable standard of physical and mental health (Art 12, ICSECR and Art 25, CRPD), by facilitating the assessment and determination of compensation and benefits in relation to the treatment and rehabilitation of veterans and Defence Force members; and
  • the rights of persons with disabilities by facilitating the determination of claims relating to treatment and rehabilitation (Art 26, CRPD).

Conclusion

This Legislative Instrument is compatible with human rights as it does not derogate from and promotes a number of human rights.

 

Repatriation Medical Authority

 

 

 

 

 

 

[1] In General Comment No. 19 (The right to social security), the Committee on Economic, Social and Cultural Rights said (at paragraph 24) this to be one of the elements of ensuring accessibility to social security.

Overview

The Repatriation Medical Authority Instrument No. 13 of 2014, published under the Veterans’ Entitlements Act 1986 and the Military Rehabilitation and Compensation Act 2004, aims to address the need for a comprehensive medical-scientific framework to assess and approve claims related to fibromyalgia and death from fibromyalgia among veterans and current or former Defence Force members. Enacted by the Repatriation Medical Authority, this instrument seeks to ensure that claims for pensions or compensation are substantiated by sound medical-scientific evidence. By establishing a Statement of Principles, the instrument delineates the minimum factors that must be present and linked to specific types of military service to establish a reasonable hypothesis connecting the condition with the service. This legislative measure is designed to streamline the claims process, ensuring that only claims supported by the Statement of Principles are accepted, thereby improving the quality of medico-scientific outcomes under the relevant Acts. The instrument ensures that the Repatriation Commission, Military Rehabilitation and Compensation Commission, Veterans’ Review Board, and Administrative Appeals Tribunal can only consider claims lodged after the specified dates unless they are upheld by the new Statement of Principles. It promotes human rights by facilitating access to social security, adequate living standards, and health care for affected individuals, aligning with international human rights standards. The instrument’s compatibility with these standards underscores its role in upholding the rights of veterans, current and former Defence Force members, and their dependents.

Scope and Application

The Repatriation Medical Authority Instrument No. 13 of 2014, concerning fibromyalgia and death from fibromyalgia, applies to individuals who have served in the Australian Defence Force and are making claims for pensions under the Veterans’ Entitlements Act 1986 or compensation under the Military Rehabilitation and Compensation Act 2004. This instrument specifies the factors that must exist and be related to certain types of service to establish a connection between fibromyalgia or death from fibromyalgia and the individual's service. The instrument is applicable nationwide, aligning with the provisions of both the VEA and the MRCA, and it sets the criteria that must be met for claims relating to fibromyalgia or death from fibromyalgia to be considered. The instrument incorporates references to diagnostic criteria and outlines the conditions under which the Repatriation Commission or the Military Rehabilitation and Compensation Commission will assess such claims. Notably, any claim lodged on or after 1 June 1994 for the VEA or 1 July 2004 for the MRCA must be upheld by this Statement of Principles to be accepted. Furthermore, the instrument is designed to ensure compatibility with human rights, promoting the rights of veterans and their dependents under various international covenants.

Key Provisions

The key provision of this legislation is Statement of Principles Instrument No. 13 of 2014 concerning fibromyalgia and death from fibromyalgia, determined by the Repatriation Medical Authority under subsection 196B(2) of the Veterans’ Entitlements Act 1986 (VEA). This Statement of Principles outlines the minimum factors that must exist and be related to specific types of service to establish a reasonable hypothesis connecting fibromyalgia or death from fibromyalgia to the circumstances of that service (paragraph 4). This includes operational, peacekeeping, hazardous, and British nuclear test defence service under the VEA, as well as warlike and non-warlike service under the Military Rehabilitation and Compensation Act 2004 (MRCA). The instrument also references the American College of Rheumatology Preliminary Diagnostic Criteria for Fibromyalgia and Measurement of Symptom Severity 2010 (paragraph 7). The obligations imposed by this Act are primarily on the Repatriation Commission, Military Rehabilitation and Compensation Commission, Veterans’ Review Board, and Administrative Appeals Tribunal. They cannot accept any claim for pension or compensation relating to fibromyalgia or death from fibromyalgia that was lodged after 1 June 1994 for the VEA and 1 July 2004 for the MRCA, unless it is upheld by this Statement of Principles (subsections 120A(3) of the VEA and 338(3) of the MRCA). This requirement ensures that all claims are assessed based on the evidence and criteria specified in the Statement of Principles. There are no explicit offences, penalties, or consequences for breach outlined in the legislation. However, the failure to adhere to the criteria set forth in the Statement of Principles could result in the rejection of claims by the relevant authorities. The legislation emphasises the importance of sound medical-scientific evidence in determining eligibility for benefits and compensation. This ensures that the claims process is fair, transparent, and based on reliable evidence, thereby protecting the rights of veterans and service personnel.

Legal classification tags

Area of Law
Veterans Law
Instrument
Statutory Instrument
Concepts
Definitions & Interpretation
Offence Provisions
Licensing & Registration
Reporting & Disclosure Obligations

Interactions

Authorises

All Versions

Sourced from the Federal Register of Legislation at 26 August 2026. For the latest information on Australian Government law please go to https://www.legislation.gov.au.